Outcomes for Patients with Clinical Lymphadenopathy Treated with Radical Prostatectomy-Reference-Cited by-同舟云学术

Outcomes for Patients with Clinical Lymphadenopathy Treated with Radical Prostatectomy

Published:2016-02 Issue:2 Volume:69 Page:193-196
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Moschini Marco,Briganti Alberto,Murphy Christopher R.,Bianchi Marco,Gandaglia Giorgio,Montorsi Francesco,Quevedo J. Fernando,Carlson Rachel,Kwon Eugene,Karnes R. Jeffrey

Publisher

Elsevier BV

Subject

Urology

Reference10 articles.

1. Predicting 15-year prostate cancer specific mortality after radical prostatectomy;Eggener;J Urol,2011

2. Predicting survival of patients with node-positive prostate cancer following multimodal treatment;Abdollah;Eur Urol,2014

3. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era;Boorjian;J Urol,2007

4. Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy;Touijer;Eur Urol,2014

5. More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer;Abdollah;Eur Urol,2015

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The diagnostic accuracy of ⁶⁸Ga‐PSMA‐PET/CT in primary staging of patients with high‐risk nonmetastatic prostate cancer treated with radical prostatectomy: A single‐center cohort analysis;The Prostate;2023-09-26

2. Pelvic lymph node dissection in high-risk prostate cancer;International braz j urol;2022-01

3. Radical Prostatectomy Outcomes in Patients with Clinical Lymph Node Involvement from The Turkish Urooncology Database;The Bulletin of Urooncology;2021-12-01

4. Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting;La radiologia medica;2021-11-30

5. Contemporary outcomes following robotic prostatectomy for locally advanced and metastatic prostate cancer;Translational Andrology and Urology;2021-05